The independent source for health policy research, polling, and news.
261 - 280 of 112,362 Results
The federal government has paid to supply the test strips, which also check for other contaminants, to states since 2021, but the Trump administration now contends that harm-reduction measures encourage drug use, The New York Times reports. Experts assert that more information is better, and the distribution of test strips can stave off overdoses and encourage people who use drugs to exercise more caution.
Today's early morning highlights from the major news organizations.
Opinion writers tackle these public health topics.
Experts are worried that the use of offshore reinsurance in countries that often benefit from looser regulations will create a more risky environment in the life insurance sector. Many retired Americans rely on life insurance to provide financial security through annuities, Bloomberg notes.
CDC data indicate that just 61% of people in nursing homes and less than 50% of healthcare workers in the facilities received the annual vaccination during the 2024-25 flu season. The Centers for Disease Control and Prevention also reported six more pediatric deaths from flu.
The medications being offered will include the diabetes drug metformin, and the blood thinner Xarelto, CBS News reports. Also in the news: Roundup lawsuits, weight loss pill Foundayo, gabapentin for traumatic brain injuries, and more.
Those who called 988 and pressed 3 or texted PRIDE were once connected to crisis counselors trained to provide services for LGBTQ+ youth. According to MedPage Today, the Trump administration has now pledged to revive the dedicated line after cutting it last summer. A 2021 study by The Trevor Project shows that LGBTQ+ youth are four times more likely to seriously consider and attempt suicide compared with their peers.
Multiple scientists were dismissed Friday, effectively immediately. The board typically consists of 25 members from various scientific fields, appointed by the president for a six-year term. Critics say the scientists' dismissal, along with funding cuts, could have national consequences.
A Trump administration official said the man who rushed a security checkpoint "set out to target folks in the administration” and claimed to be a “friendly federal assassin.” Those who know the man described him as "a very nice guy,” "polite," and "peaceful." Plus, security concerns arise.
Today's early morning highlights from the major news organizations.
Editorial writers discuss these public health topics.
Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on children's health, solar power, microplastics, peptides, and more.
The measure, which is backed by Democratic Gov. Ned Lamont, would also require insurance coverage and allow Connecticut to purchase vaccines from sources other than the CDC.
The findings, published in the Journal of the American College of Cardiology, said that many deaths in the researchers' study could be explained by a range of causes, including hypertensive heart disease, dilated cardiomyopathy, substance-related cardiomyopathy, and normal heart primary electrical disease. "As a consequence, efforts should also be made to study the diagnosis and management of heart conditions other than ischemic cardiac disease," an accompanying editorial said.
Active-duty and retired service members have been contending with delayed and unpaid claims since the rollout of new Tricare contracts more than a year ago.
According to BioSpace, Moderna withdrew its approval application in the United States last May for the vaccine, which will carry the brand name mCOMBRIAX. The timeline for resubmission with the FDA remains uncertain.
A Senate-approved budget resolution to fund Homeland Security agencies does not include language to block funds from family planning clinics. Some lawmakers want the defunding provision included in the final bill. Congress must act before July.
To be eligible, certain breakthrough devices would have to be part of an Investigational Device Exemption study enrolling Medicare beneficiaries and assessing clinical outcomes agreed upon by the FDA and CMS, Modern Healthcare reported. Plus, President Donald Trump strikes a most-favored-nation deal with the final pharmaceutical holdout.
Today's early morning highlights from the major news organizations.
Opinion writers examine these public health topics.
© 2026 KFF